Abstract

Salacia debilis Walp., (Celastraceae) is used traditionally in West Africa for the treatment of malaria. However, no scientific reports validating these effects and its active constituents are on record. Therefore, this study is aimed at evaluating the antimalarial effects, of its ethanolic extract and isolated compounds against Plasmodium falciparum 3D7 and P. berghei ANKA strains. Using chromatographic, spectrometric and spectroscopic techniques three compounds were isolated and characterised. The extract of S. debilis was active against P. falciparum 3D7, in an in vitro assay with IC50 of 12.0 ± 0.32 µg/ml. The three isolated compounds, namely 1,10-dihydroxy-6H-benzo[c]chromen-6-one (1), 8- hydroxy-3,4-dimethoxydibenzo[b,d]furan-1-carboxylic acid (2) and benzyl-2-methoxybenzoate (3), also showed antimalarial activity against Plasmodium berghei ANKA strain in curative and suppressive in vivo assays. The ethanolic extract and isolated compounds of S. debilis possess antimalarial effects. The isolated compounds may be responsible, at least in part, for the observed activities of the extract.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.